Details for Patent: 5,916,893
✉ Email this page to a colleague
Summary for Patent: 5,916,893
| Title: | Treatment of a latent infection of herpes virus |
| Abstract: | A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing. |
| Inventor(s): | Field; Hugh John (Cambridge, GB), Thackray; Alana Maureen (Cambridge, GB), Bacon; Teresa Helen (Epsom, GB), Sutton; David (Phoenixville, PA), Vere Hodge; Richard Anthony (Reigate, GB) |
| Assignee: | SmithKline Beecham p.l.c. (Brentford, GB) |
| Application Number: | 08/845,720 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,916,893
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,916,893
International Family Members for US Patent 5,916,893
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 669 | ⤷ Try a Trial | |||
| African Regional IP Organization (ARIPO) | 9701001 | ⤷ Try a Trial | |||
| Austria | 208198 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
